Harmony Biosciences Expands Patients At The Heart Grant Program And Reinforces Its Commitment To Newly Uninsured Patients
- Monday, April 27, 2020, 7:13
- PR Newswire
- Add a comment
PLYMOUTH MEETING, Pa., April 27, 2020 /PRNewswire/ — Harmony Biosciences, LLC (“Harmony”), a private pharmaceutical company dedicated to developing and commercializing new treatment options for people living with rare diseases, today announced the company will expand narcolepsy community…
About the Author
admin has written 21636 stories on this site.